THE POTENTIAL OF HYBRID ANTIBODIES SECRETED BY HYBRID-HYBRIDOMAS IN TUMOR-THERAPY

THE POTENTIAL OF HYBRID ANTIBODIES SECRETED BY HYBRID-HYBRIDOMAS IN TUMOR-THERAPY

Detalhes bibliográficos
Main Authors:	Clark, M, Gilliland, L, Waldmann, H
Formato:	Journal article
Publicado em:	1987

Registos relacionados

The potential of hybrid antibodies secreted by hybrid-hybridomas in tumour therapy.
Por: Clark, M, et al.
Publicado em: (1988)

Hybrid antibodies for therapy.
Por: Clark, M, et al.
Publicado em: (1988)

THERAPY WITH HYBRID ANTIBODIES
Por: Clark, M, et al.
Publicado em: (1989)

Development of mouse hybridoma secreting anti-acanthamoeba antibodies /
Por: Hala Abdulkareem Rasheed, 1980-, author, et al.
Publicado em: (2015)

Development of mouse hybridoma secreting anti-acanthamoeba antibodies [electronic resource] /
Por: Hala Abdulkareem Rasheed, 1980-, author
Publicado em: (2015)

Design of an Expression System for Rapid Production of Tri-Functional Antibody Substitution of Hybrid Hybridoma Technology
Por: Mohammad Reza Dehghani, et al.
Publicado em: (2018-03-01)

Universal bispecific antibody for targeting tumor cells for destruction by cytotoxic T cells.
Por: Gilliland, L, et al.
Publicado em: (1988)

Fusion efficiency for hybridoma production in hybridoma technology /
Por: Universiti Teknologi Malaysia. Fakulti Kejuruteraan Kimia dan Kejuruteraan Sumber Asli
Publicado em: (1990)

Screening individual hybridomas by microengraving to discover monoclonal antibodies
Por: Ogunniyi, Adebola Oluwakayode, et al.
Publicado em: (2012)

Generation of the first monoclonal antibody using mouse hybridomas
Por: Brunangelo Falini
Publicado em: (2022-12-01)

T-cell killing of target cells induced by hybrid antibodies: comparison of two bispecific monoclonal antibodies.
Por: Clark, MR, et al.
Publicado em: (1987)

Monoclonal antibody technology human hybridomas the production and characterization of rodent and
Por: 329577 Campbell, Ailsa M.
Publicado em: (1984)

High-throughput single-cell screening of viable hybridomas and patient-derived antibody-secreting cells using punchable microwells
Por: Kaat Rubben, et al.
Publicado em: (2024-12-01)

Serum-free media in hybridoma culture and monoclonal antibody production /
Por: 322832 Glassy, Mark C., et al.

Continuous antibody production by phytohemagglutinin-L-aggregated hybridoma cells
Por: Takamatsu, Hiroyuki, et al.
Publicado em: (1999)

MANUFACTURING OF HYBRIDOMAS-PRODUCERS OF MONOCLONAL ANTIBODIES TO BRUCELLOSIS AGENT ANTIGENS
Por: G. V. Kuklina, et al.
Publicado em: (2017-06-01)

Hybridoma technology: the preferred method for monoclonal antibody generation for in vivo applications
Por: Samantha Zaroff, et al.
Publicado em: (2019-09-01)

Nanovesicles released by OKT3 hybridoma express fully active antibodies
Por: Mariantonia Logozzi, et al.
Publicado em: (2021-01-01)

Binding Affinity Measurement of Antibodies from Crude Hybridoma Samples by SPR
Por: Dorin Ndao, et al.
Publicado em: (2014-11-01)

Role of processing of N-linked oligosaccharides in control of immunoglobulin secretion from rat hybridomas
Por: Hashim, Onn Haji, et al.
Publicado em: (1987)

Phenotypic changes in growth-arrested T cell hybrids: A possible avenue to produce functional T cell hybridoma
Por: Koichi eKubota, et al.
Publicado em: (2014-05-01)

Rapid Hybridoma Screening Method for the Identification of Monoclonal Antibodies to Low-Abundance Cytoplasmic Proteins
Por: L.A. O’Reilly, et al.
Publicado em: (1998-11-01)

Hybridoma technology: is it still useful?
Por: Jane Zveiter Moraes, et al.
Publicado em: (2021-01-01)

Enhancement of monoclonal antibody productivity by promoting active hypothermic growth in hybridoma cells
Por: Chong, Sun Li, et al.
Publicado em: (2009)

Monoclonal antibody production: media optimization for enhancement the cell viability of hybridoma cell
Por: Mel, Maizirwan, et al.
Publicado em: (2008)

Kinetics of hybridoma growth and monoclonal antibody production in serum and chemically defined medium /
Por: Mohd. Nazlee Kamal, et al.

Human IgA Monoclonal Antibodies That Neutralize Poliovirus, Produced by Hybridomas and Recombinant Expression
Por: Rama Devudu Puligedda, et al.
Publicado em: (2020-02-01)

Application of In-Cell ELISA assay for hybridoma screening and selection of promising producers of monoclonal antibodies
Por: I.I. Stepanova, et al.
Publicado em: (2022-12-01)

A hybridoma-derived monoclonal antibody with high homology to the aberrant myeloma light chain.
Por: Ghasidit Pornnoppadol, et al.
Publicado em: (2021-01-01)

Therapy with monoclonal antibodies. An in vivo model for the assessment of therapeutic potential.
Por: Isaacs, J, et al.
Publicado em: (1992)

Use of tangential flow filtration in perfusion propagation of hybridoma cells for production of monoclonal antibodies /
Por: 419923 Velez, Daniel, et al.

Dichloroacetate increases cell and antibody yields in batch cultures of a hybridoma cell line.
Por: Murray, K, et al.
Publicado em: (1996)

Polymeric Approach to Adjuvant System in Antibody Production against Leishmaniasis Based on Hybridoma Technology
Por: Asli Pinar Zorba Yildiz, et al.
Publicado em: (2022-12-01)

Correction: Identification and Structural Characterization of Interneurons of the Brain by Monoclonal Antibodies of the Würzburg Hybridoma Library.
Por: Beatriz Blanco Redondo, et al.
Publicado em: (2013-01-01)

Identification and structural characterization of interneurons of the Drosophila brain by monoclonal antibodies of the würzburg hybridoma library.
Por: Beatriz Blanco Redondo, et al.
Publicado em: (2013-01-01)

Diversity of the antibody response to tetanus toxoid: comparison of hybridoma library to phage display library.
Por: Mahsa Sorouri, et al.
Publicado em: (2014-01-01)

Control of Mycoplasma contamination in hybridoma technology
Por: Vera Bongertz, et al.
Publicado em: (1988-06-01)

Reshaping human antibodies for therapy.
Por: Riechmann, L, et al.
Publicado em: (1988)

Obtaining and Characterization of Hybridomas Producing Monoclonal Antibodies to Shiga-Like Toxins of I and II Types
Por: G. V. Kuklina, et al.
Publicado em: (2021-10-01)

Cloning and Characterization of a Hybridoma Secreting a 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-Specific Monoclonal Antibody and Recombinant F(ab)
Por: Lawrence K. Silbart, et al.
Publicado em: (2013-03-01)